The Cigna Group (CI) Insider Trading

Last 12 months

Insiders bought $1000k and sold $66.8M on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. Chief Accounting Officer Jamie G Kates sold $268k on Jun 12, 28% of their stake, outside a plan.

Net open-market

−$65.8M

1 buy · 7 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

1 / 4

executives and directors

Last open-market buy

Nov 2025

Nov 3, 2025

Get an email when CI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 3	Everett Neville See Remarks	Sold10b5-1 plan	617	$284.05	$175k	11%	Form 4
Aug 18	Nicole S Jones See Remarks	Sold10b5-1 plan	2,677	$279.61	$749k	8.9%	Form 4
Aug 4	Nicole S Jones See Remarks	Sold10b5-1 plan	19,436	$276.27	$5.37M	39%	Form 4
Jun 12	Jamie G Kates Chief Accounting Officer	SoldNo plan	899	$298.61	$268k	28%	Form 4
May 12	David Cordani Chairman & CEO	Sold10b5-1 plan 13 parts	201,878	$292.82 average	$59.1M	23%	Form 4
Mar 2	Everett Neville See Remarks	Sold10b5-1 plan	1,719	$288.91	$497k	23%	Form 4
Mar 2	Nicole S Jones See Remarks	Sold10b5-1 plan	2,307	$288.91	$667k	6.3%	Form 4
Nov 3, 2025	David Cordani Chairman & CEO	Bought	4,134	$241.88	$1000k	0.7%	Form 4
Oct 3, 2025	Brian C Evanko See Remarks	Sold10b5-1 plan	5,368	$300.00	$1.61M	9.2%	Form 4
Aug 15, 2025	Nicole S Jones See Remarks	Sold10b5-1 plan	28,526	$300.00	$8.56M	49%	Form 4
Mar 14, 2025	Elder Granger Director	Sold10b5-1 plan	2,376	$310.35	$737k	30%	Form 4
Mar 7, 2025	Noelle K Eder See Remarks	Sold10b5-1 plan	9,944	$320.00	$3.18M	42%	Form 4
Mar 3, 2025	David Cordani Chairman & CEO	Sold10b5-1 plan	26,527	$308.12	$8.17M	4.1%	Form 4
Mar 3, 2025	Nicole S Jones See Remarks	Sold10b5-1 plan	4,904	$308.12	$1.51M	14%	Form 4

Sep 310b5-1 plan
Everett Neville
See Remarks · sold 617 at $284.05
$175k
11% of stake
Aug 1810b5-1 plan
Nicole S Jones
See Remarks · sold 2,677 at $279.61
$749k
8.9% of stake
Aug 410b5-1 plan
Nicole S Jones
See Remarks · sold 19,436 at $276.27
$5.37M
39% of stake
Jun 12No plan
Jamie G Kates
Chief Accounting Officer · sold 899 at $298.61
$268k
28% of stake
May 1210b5-1 plan
David Cordani
Chairman & CEO · sold 201,878 at avg $292.82
$59.1M
23% of stake
Mar 210b5-1 plan
Everett Neville
See Remarks · sold 1,719 at $288.91
$497k
23% of stake
Mar 210b5-1 plan
Nicole S Jones
See Remarks · sold 2,307 at $288.91
$667k
6.3% of stake
Nov 3, 2025
David Cordani
Chairman & CEO · bought 4,134 at $241.88
$1000k
0.7% of stake
Oct 3, 202510b5-1 plan
Brian C Evanko
See Remarks · sold 5,368 at $300.00
$1.61M
9.2% of stake
Aug 15, 202510b5-1 plan
Nicole S Jones
See Remarks · sold 28,526 at $300.00
$8.56M
49% of stake
Mar 14, 202510b5-1 plan
Elder Granger
Director · sold 2,376 at $310.35
$737k
30% of stake
Mar 7, 202510b5-1 plan
Noelle K Eder
See Remarks · sold 9,944 at $320.00
$3.18M
42% of stake
Mar 3, 202510b5-1 plan
David Cordani
Chairman & CEO · sold 26,527 at $308.12
$8.17M
4.1% of stake
Mar 3, 202510b5-1 plan
Nicole S Jones
See Remarks · sold 4,904 at $308.12
$1.51M
14% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Hospital & Medical Service Plans

CNCCentene Corporation

ELVElevance Health, Inc.

HUMHumana Inc.

UNHUnitedHealth Group Incorporated

MOHMolina Healthcare Inc.

BRK-ABerkshire Hathaway Inc

PGRProgressive Corporation

METMetLife Inc.

Spot a number that looks wrong? Check it in CI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.